Related Experiment Video
Updated: Apr 3, 2026
Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Role of RUNX2 in Breast Carcinogenesis
Daniel Wysokinski1, Janusz Blasiak2, Elzbieta Pawlowska3
1Department of Molecular Genetics, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland. dwysokinski@gmail.com.
Abstract:
RUNX2 is a transcription factor playing the major role in osteogenesis, but it can be involved in DNA damage response, which is crucial for cancer transformation. RUNX2 can interact with cell cycle regulators: cyclin-dependent kinases, pRB and p21Cip1 proteins, as well as the master regulator of the cell cycle, the p53 tumor suppressor. RUNX2 is involved in many signaling pathways, including those important for estrogen signaling, which, in turn, are significant for breast carcinogenesis. RUNX2 can promote breast cancer development through Wnt and Tgfβ signaling pathways, especially in estrogen receptor (ER)-negative cases. ERα interacts directly with RUNX2 and regulates its activity. Moreover, the ERa gene has a RUNX2 binding site within its promoter. RUNX2 stimulates the expression of aromatase, an estrogen producing enzyme, increasing the level of estrogens, which in turn stimulate cell proliferation and replication errors, which can be turned into carcinogenic mutations. Exploring the role of RUNX2 in the pathogenesis of breast cancer can lead to revealing new therapeutic targets.
Insights
RUNX2, a key bone development factor, also drives breast cancer by interacting with cell cycle regulators and estrogen pathways. Targeting RUNX2 may offer new therapeutic strategies for breast cancer.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- RUNX2 is a critical transcription factor for osteogenesis.
- RUNX2 also participates in DNA damage response, a process vital for cancer development.
- RUNX2 interacts with key cell cycle regulators like p53, pRB, p21Cip1, and cyclin-dependent kinases.
Purpose of the Study:
- To investigate the multifaceted role of RUNX2 in breast carcinogenesis.
- To elucidate RUNX2's involvement in estrogen signaling and its impact on breast cancer.
- To identify potential therapeutic targets by understanding RUNX2's function in breast cancer pathogenesis.
Main Methods:
- Analysis of RUNX2 interactions with cell cycle regulators.
- Examination of RUNX2's role in estrogen signaling pathways.
- Investigation of RUNX2's influence on Wnt and Tgfβ signaling in breast cancer.
Main Results:
- RUNX2 promotes breast cancer development, particularly in estrogen receptor-negative cases, via Wnt and Tgfβ pathways.
- Estrogen receptor alpha (ERα) directly interacts with and regulates RUNX2 activity.
- RUNX2 upregulates aromatase, increasing estrogen levels and promoting cell proliferation and mutations.
Conclusions:
- RUNX2 plays a significant role in breast cancer pathogenesis through various signaling pathways.
- RUNX2's interaction with estrogen signaling highlights its importance in hormone-driven breast cancers.
- Targeting RUNX2 presents a promising avenue for novel breast cancer therapies.
More Related Videos
06:29Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland
Published on: June 7, 2019
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:46Epigenetic Regulation
01:37Epigenetic Regulation
X-chromosome...
02:23Abnormal Proliferation
03:17Inheritance of Chromatin Structures
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...